Cagrilintide — 10mg
Product Overview
Cagrilintide is a synthetic, long-acting analogue of amylin. Amylin is a peptide hormone co-secreted with insulin and studied for its role in nutrient-responsive signalling and communication among pancreatic, gastrointestinal and central pathways.
Research Background
Amylin-family peptides interact with receptor complexes formed from calcitonin receptors and receptor-activity-modifying proteins. Cagrilintide is investigated as a tool for studying sustained amylin-receptor engagement, receptor selectivity and the integration of amylin-related signalling with other metabolic pathways.
Current Areas of Investigation
Research includes receptor pharmacology, peptide half-life engineering, appetite and energy-balance signalling, and studies combining amylin-related pathways with other metabolic signals.
In Plain Language
Researchers are exploring how amylin signalling may influence feelings of fullness, food-intake patterns and the way biological systems coordinate energy balance after eating. Amylin-related signals are also studied for their effects on gastric emptying and communication between the pancreas, digestive system and brain.
In plain terms, cagrilintide research asks whether a longer-acting amylin signal can reduce drive toward food and help explain how fullness signals are maintained over time. Combination studies also examine how this pathway interacts with GLP-1 and other metabolic signals.
Product Specifications
- Catalogue No.: CAG10
- Vial Size: 10mg
Quality & Documentation
Lot-specific product documentation and Certificate of Analysis (COA) information may be available through AURAPEP where applicable.
Research Use Only
RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. Supplied strictly for laboratory, analytical and research purposes. Not intended for self-administration or to diagnose, treat, cure or prevent any disease.
